bioRxivCell Biology
Alpha kinase 3 signaling at the M-band maintains sarcomere integrity and proteostasis in striated muscle.
J. W. McNamara, B. L. Parker, H. K. Voges, N. R. R. Mehdiabadi, F. Bolk, D. D. Chung, N. Charitakis, J. Molendijk, S. Lal, M. Ramialison, K. Karavendzas, H. L. Pointer, P. Syrris, L. R. Lopes, E. M. Perry, G. S. Lynch, R. J. Mills, J. E. Hudson, K. I. Watt, E. R. Porrello, D. A. Elliott
Abstract
Pathogenic variants in alpha kinase 3 (ALPK3) cause cardiomyopathy and musculoskeletal disease. How ALPK3 mutations result in disease remains unclear because little is known about this atypical kinase. Using a suite of engineered human pluripotent stem cells (hPSCs) we show that ALPK3 localizes to the M-Band of the sarcomere. ALPK3 deficiency disrupted sarcomeric organization and calcium kinetics in hPSC-derived cardiomyocytes and reduced force generation in cardiac organoids. Phosphoproteomic profiling identified ALPK3-dependant phospho-peptides that were enriched for sarcomeric components of the M-band and the ubiquitin-binding protein SQSTM1. Analysis of the ALPK3 interactome confirmed binding to M-band proteins including SQSTM1. Importantly, in hPSC-derived cardiomyocytes modeling ALPK3 deficiency and cardiomyopathic ALPK3 mutations, sarcomeric organization and M-band localization ofSQSTM1 were abnormal. These data suggest ALPK3 has an integral role in maintaining sarcomere integrity and proteostasis in striated muscle. We propose this mechanism may underly disease pathogenesis in patients with ALPK3 variants.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten
Lisa Leinhos, Paul J. Robinson, … Katja Gehmlich·Scientific ReportsPeer-reviewed·Mar 24, 2025
- Clinical Validity of Autosomal Dominant ALPK3 Loss-of-function Variants as a Cause of Hypertrophic Cardiomyopathy
Sophie Hespe, Emma S. Singer, … Jodie Ingles·Circulation Genomic and Precision MedicinePeer-reviewed·Apr 21, 2025
- Alpha Protein Kinase 3 Gene Therapy Restores Heart Function in Mouse and Human Models of Cardiomyopathy
James W. McNamara, Ellen B. Keen, … David A. Elliott·Nature Cardiovascular ResearchPeer-reviewed·Aug 19, 2026
- Missense variants in the myosin binding domains of MYBPC3 and MYBPHL impair sarcomere incorporation
Kelly Araujo, Hannah E. Cizauskas, … David Y. Barefield·bioRxiv·Sep 29, 2025
- Molecular mechanisms of altered contraction with the β-myosin R403Q mutation in porcine ventricular muscle and a human stem cell-derived cardiomyocyte model.
Sonette Steczina, Saffie E. Mohran, … Michael Regnier·Journal of Molecular and Cellular CardiologyPeer-reviewed·Oct 28, 2025
- AAV-Delivered RNAi Targeting Mutant LDB3 Prevents and Reverses Myofibrillar Myopathy through Mechanosignaling Restoration
Pankaj Pathak, Jessica Palmeri, … Ami K. Mankodi·bioRxiv·Mar 31, 2026